Journal of Medical Economics, Volume 20, Issue 11 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 20, Issue 11 (2017)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Volume 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Diabetes

Report
Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States
B. Hunt, C.C. McConnachie, C. Gamble & T. Dang-Tan
Pages: 1117-1120
Published online: 11 Jul 2017
AbstractforEvaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States | Full Text | References | PDF (682.2 KB)
  • 784 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Letter
Re: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-702
Jayeshkumar Patel, Xiaohui Zhao, Drishti Shah, Khalid Alhussain & Khalid Kamal
Pages: 1121-1122
Published online: 11 Aug 2017
CitationforRe: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-702 | Full Text | References | PDF (187.8 KB)
  • 247 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Letter
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
Catherine Saint-Laurent Thibault, Divya Moorjaney, Michael L. Ganz, Bruce Sill, Shalini Hede, Yong Yuan & Boris Gorsh
Pages: 1123-1125
Published online: 11 Aug 2017
First Page PreviewforReply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States | Full Text | References | PDF (465.8 KB)
  • 228 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Hospital Practice

Letter
Re: A dynamic approach for outpatient scheduling
Cheryl Lim & Rahul Chodhari
Page: 1126
Published online: 11 Aug 2017
CitationforRe: A dynamic approach for outpatient scheduling | Full Text | References | PDF (125.2 KB)
  • 264 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Letter
Reply: A dynamic approach for outpatient scheduling
James Creps & Vahid Lotfi
Page: 1127
Published online: 09 Aug 2017
CitationforReply: A dynamic approach for outpatient scheduling | Full Text | PDF (121.2 KB)
  • 219 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective
Shraddha Chaugule & Claudia Graham
Pages: 1128-1135
Published online: 11 Aug 2017
AbstractforCost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective | Full Text | References | PDF (797.8 KB) | Supplemental
  • 2681 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden
Ancilla W. Fernandes, Bingcao Wu & Ralph M. Turner
Pages: 1136-1147
Published online: 14 Aug 2017
AbstractforBrain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden | Full Text | References | PDF (1.5 MB)
  • 1898 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Cardiology

Article
Risk of major amputation or death among patients with critical limb ischemia initially treated with endovascular intervention, surgical bypass, minor amputation, or conservative management
Ehrin J. Armstrong, Michael P. Ryan, Erin R. Baker, Brad J. Martinsen, Harry Kotlarz & Candace Gunnarsson
Pages: 1148-1154
Published online: 16 Aug 2017
AbstractforRisk of major amputation or death among patients with critical limb ischemia initially treated with endovascular intervention, surgical bypass, minor amputation, or conservative management | Full Text | References | PDF (815.6 KB) | Supplemental
  • 2671 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations
Rei Goto, Akihito Uda, Shinzo Hiroi, Kosuke Iwasaki, Kenta Takashima & Mototsugu Oya
Pages: 1155-1162
Published online: 16 Aug 2017
AbstractforCost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations | Full Text | References | PDF (994.8 KB) | Supplemental
  • 1702 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations
Rei Goto, Akihito Uda, Shinzo Hiroi, Kosuke Iwasaki, Kenta Takashima & Junichi Kurebayashi
Pages: 1163-1169
Published online: 16 Aug 2017
AbstractforCost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations | Full Text | References | PDF (923.6 KB) | Supplemental
  • 1314 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis
Bingcao Wu, Gaurav Deshpande, Tao Gu, Breanna Popelar, Michael Philbin & George J. Wan
Pages: 1170-1177
Published online: 11 Aug 2017
AbstractforDemographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis | Full Text | References | PDF (868.5 KB)
  • 703 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class
Robert Dufour, Janis Pruett, Nan Hu, Cassandra Lickert, Stephen Stemkowski, Yuen Tsang, Daniel Lane & William Drake III
Pages: 1178-1186
Published online: 11 Aug 2017
AbstractforHealthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class | Full Text | References | PDF (876.9 KB)
  • 4100 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry

Article
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands
Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri, Kristel Van Impe, Tom R. Denee & Pieter J. T. Dries
Pages: 1187-1199
Published online: 14 Aug 2017
AbstractforCost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands | Full Text | References | PDF (18.3 MB)
  • 2196 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura
Prina Z. Donga, Sara P. Bilir, Gregg Little, Tim Babinchak & Julie Munakata
Pages: 1200-1206
Published online: 08 Sep 2017
AbstractforComparative treatment-related adverse event cost burden in immune thrombocytopenic purpura | Full Text | References | PDF (693.6 KB) | Supplemental
  • 1238 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease
Julia Lowin, Kavita Sail, Rakhi Baj, Yash J. Jalundhwala, Thomas S. Marshall, Henrietta Konwea & K. R. Chaudhuri
Pages: 1207-1215
Published online: 21 Sep 2017
AbstractforThe cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease | Full Text | References | PDF (1.5 MB)
  • 4839 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Corrigenda

Correction
Corrigendum to: Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson’s disease
Clement Francois, Italo Biaggioni, Cyndya Shibao, Augustina Ogbonnaya, Huai-Che Shih, Eileen Farrelly, Adam Ziemann & Amy Duhig
Page: 1216
Published online: 08 Sep 2017
CitationforCorrigendum to: Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson’s disease | Full Text | PDF (91.2 KB)
  • 525 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

An assessment of the direct and indirect costs of bladder cancer preceding and following a cystectomy: a real-world evidence study
Joseph Tkacz et al.
Article | Published online: 19 Jul 2024
Open Access
Impact of COVID-19 on work loss in the United States- A retrospective database analysis
Jennifer Judy et al.
Article | Published online: 18 Jul 2024
Open Access
Cost analysis of patiromer versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK
Antonio Ramirez de Arellano et al.
Article | Published online: 18 Jul 2024
Open Access
The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis
Michael Charlton et al.
Article | Published online: 17 Jul 2024
Open Access
View all latest articles